- Home
- VNRX vs NRXP Comparison
VNRX vs NRXP Comparison
Compare VNRX & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNRX
- NRXP
- Stock Information
- Founded
- VNRX N/A
- NRXP 2015
- Country
- VNRX United States
- NRXP United States
- Employees
- VNRX N/A
- NRXP N/A
- Industry
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- VNRX Health Care
- NRXP Health Care
- Exchange
- VNRX Nasdaq
- NRXP Nasdaq
- Market Cap
- VNRX 69.7M
- NRXP 73.7M
- IPO Year
- VNRX N/A
- NRXP N/A
- Fundamental
- Price
- VNRX $0.41
- NRXP $2.66
- Analyst Decision
- VNRX Strong Buy
- NRXP Strong Buy
- Analyst Count
- VNRX 4
- NRXP 5
- Target Price
- VNRX $3.50
- NRXP $31.60
- AVG Volume (30 Days)
- VNRX 1.2M
- NRXP 455.2K
- Earning Date
- VNRX 11-14-2025
- NRXP 11-14-2025
- Dividend Yield
- VNRX N/A
- NRXP N/A
- EPS Growth
- VNRX N/A
- NRXP N/A
- EPS
- VNRX N/A
- NRXP N/A
- Revenue
- VNRX $1,319,252.00
- NRXP N/A
- Revenue This Year
- VNRX $324.32
- NRXP N/A
- Revenue Next Year
- VNRX $247.82
- NRXP $395.09
- P/E Ratio
- VNRX N/A
- NRXP N/A
- Revenue Growth
- VNRX 35.10
- NRXP N/A
- 52 Week Low
- VNRX $0.40
- NRXP $1.12
- 52 Week High
- VNRX $0.94
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- VNRX 32.66
- NRXP 35.34
- Support Level
- VNRX $0.42
- NRXP $2.91
- Resistance Level
- VNRX $0.48
- NRXP $3.38
- Average True Range (ATR)
- VNRX 0.04
- NRXP 0.21
- MACD
- VNRX 0.00
- NRXP -0.07
- Stochastic Oscillator
- VNRX 4.14
- NRXP 8.75
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.